Palantir Stock Falls After Citi Trims Price Target
π Citigroup downgraded Palantir Technologies' price target from $260 to $210 while maintaining a buy rating.
π The stock of Palantir (PLTR) fell approximately 2% in midday trading after the analyst action, trading around $143.
π° Palantir reported strong first-quarter results with adjusted earnings of 25 cents per share on revenue of $1.41 billion, a 70% increase year-over-year.
π GuruFocus has identified four warning signs regarding Palantir Technologies (PLTR).
π¦ Large institutional investors like Norges Bank, Vanguard, and State Street added to their positions in the company.
πΌ Conversely, insiders sold more than 1 million shares of Palantir stock over the past 90 days.
π― The average analyst price target for PLTR is currently set near $194 with a consensus moderate buy rating.
β οΈ Investors are concerned about Palantir's rich valuation despite a sharp rally in the past year.
π Competition concerns remain high for the data-analytics company operating globally.
βοΈ Regulatory setbacks have impacted Palantir specifically in Europe and the United Kingdom markets.
- Palantir reported first-quarter results that topped Wall Street's estimates with adjusted earnings of 25 cents per share on revenue of $1.41 billion.
- Revenue grew 70% year-over-year, demonstrating strong business expansion and demand for the data-analytics company's solutions.
- Despite Citi lowering its price target, the analyst maintained a buy rating, which still points to significant upside from the shares' recent trading level around $143.
- Large institutional holders including Norges Bank, Vanguard, and State Street added to their positions in the stock, indicating continued confidence from major investors.
- Citi downgraded Palantir's price target from $260 to $210, creating immediate downward pressure on shares that fell about 2% to trade around $143.
- Palantir's valuation is described as remaining rich, which poses a downside risk given high market expectations and recent volatility.
- Insiders sold more than 1 million shares in the past 90 days, signaling potential lack of confidence from company leadership despite institutional accumulation.
- The stock faces ongoing concerns regarding competitive threats and regulatory setbacks specifically in Europe and the U.K.